Breast Cancer Drugs are More Expensive in the 7th Congressional District in Maryland than in Foreign Countries

Publication

Breast Cancer Drugs are More Expensive in the 7th Congressional District in Maryland than in Foreign Countries

Abstract

The Special Investigations Division of the House Committee on Government Reform investigated the pricing of five commonly prescribed brand-name prescription drugs for breast cancer in Representitive Cumming’s district in Maryland. The report states uninsured women in this district face substantially higher costs, with the average price for these drugs being 155% higher than in Canada, the U.K., France, and Italy. Breast cancer drugs are over three times more expensive in this district than in Canada and France. These findings underscore the disparity in breast cancer drug prices between Rep. Cummings's district and other countries, with substantial implications for the financial burden on patients.